Sign In

За нас

Assoc.prof. Kameliya Zhechkova Bratoeva


Medical University of Varna "Prof. d-r Paraskev Stoyanov", Bulgaria

Катедра: Department of Physiology and pathophysiology
УС:
Е-поща: k_brat@abv.bg
Телефон: 052/ 677 071

 

Биография

 

Dr. Kameliya Bratoeva, MD, PhD is a professor of Pathophysiology at the Medical University of Varna, Bulgaria.  She graduated the Medical University of Varna in 2000. In 2007, she was appointed as an assistant professor in the Department of  Pathophysiology of the Medical University of Varna. Her consecutive career development is starting as an assistant professor (2007-2015), chief assistant professor (2016-2018) and аssociate professor (2018). In 2008 she did her first specialization in Social medicine and health management (2008) and in 2012 was done her second specialization in Pathophysiology.

In 2016 Dr. Kameliya Bratoeva defended successfully her PhD thesis on the topic „Mechanism of Hepatocyte Survival in Experimental Model of Non-alcoholic Fatty Liver and Antioxidants Intake". Her major research interest is in testing and identifying bio-markers for early detection and treatment of cardiometabolic, hepatic metabolic disorders and cancer. There are over 40 publications and participation in scientific congresses. Additional research areas and subareas- Molecular medicin; Biomarkers; Immunology; Cancer; Metabolic syndrome; hepatic disorders; obesity, Biotechnology and ecological foods. Dr. Kameliya Bratoeva is an author of a monograph entitled „Disorders of metabolic syndrome and non-alcoholic fatty liver disease. General pathophysiological mechanisms and links."


Публикации

Selected scientific publications

  1. Bratoeva K, Nikolova S, Merdzhanova A, Stoyanov G, Dimitrova E, Kashlov J, Conev N,  Radanova M. Association between serum ck-18 levels and the degree of liver damage in fructose-induced metabolic syndrome. Journal of Metabolic Syndrome and Related Disorders, 2018 6(7): 350-357. ISSN: 1557-8518
  2. Bratoeva K, Mariya Radanova, Albena Merdzhanova, Ivan Donev.Protective Role of S-Adenosylmethionine Against Fructose-Induced Oxidative Damage in Obesity. Journal of Mind and Medical Sciences. 2017; 4(2): 163-171. ISSN: 2392-7674
  3. Bratoeva K, Stoyanow S. G, Merdzhanova A., Radanova. Manifestations of Renal Impairment in Fructose-induced Metabolic Syndrome. M. CUREUS, 2017;9(11):e1826. ISSN 2168-8184.
  4. G. Bekyarova, M. Tzaneva, K. Bratoeva, I. Kotzev.Heme-oxygenase-1 upregulated by s-adenosylmethionine. potential protection against non-alcoholic fatty liver induced by high fructose diet. FARMACIA. 2017; 65 (2), 262-267 .
  5. Bratoeva K, Bekyarova G. Irina Ivanova, Andrei Kotzev, Minka Hristova at al. 4-Hydroxynonenal (HNE) and hepatic injury related to chronic oxidative stress. Biotechnology & Biotechnological Equipment 2019, VOL. 33, NO. 1, 1544–1552
  6. Veselina Panayotova, Albena Merdzhanova,Diana A. Dobreva, Kameliya Bratoeva, Lubomir Makedonski. Nutritional composition, bioactive compounds and health-beneficial properties of black sea shellfish J of IMAB. 2020 Jul-Sep;26(3)
  7. K. Bratoeva, M. Radanova, A. Merdzhanova.Еffect of аllopurinol on oxidative stress in obesity and liver content of free fatty acids.J. BioSci. Biotechnol. 2015, SE/ONLINE: 91-96.ISSN: 1314-6446
  8. Bratoeva K, Bekyarova G, Kiselova Y, Radanova M, Ivanova D. Мetabolic changes in experimental model of  metabolic syndrom- induced by high- fructose diet in rats. Scripta Scientifica Medica, 2010;42 (4), 233-235.
  9. Bekyarova G., Bratoeva K, Bekyarov N.Uric аcid аnd vascular disorders in metabolic syndrome.Cardiovascular Diseases 2013,44(1),40-44.ISSN 0204-6865
  10. George S. Stoyanov, Ina Kobakova, Lyuben Stoev, Hristo Popov, Savi R. Shishkov, Kameliya Bratoeva. Histological Changes in Severe Diabetic Fetopathy: An Autopsy Case Report. Cureus. 2019/3; 11 (3) e4199.
  11. Ivanova, N. A., Trapani, A., Franco, C. D., Mandracchia, D., Trapani, G., Franchini, C., Bratoeva K et al. (2019). In vitro and ex vivo studies on diltiazem hydrochloride-loaded microsponges in rectal gels for chronic anal fissures treatment. Int. J. Pharm. 25557, 53–65.
  12. E. Dimitrova, B. Chaushev, N. Conev, K. Bratoeva et al. Role of the pretreatment 18F-fluorodeoxyglucose positron emission tomography maximal standardized uptake value in predicting outcomes of colon liver metastasesand that value's association with Beclin-1 expression. BioScience Trends Vol. 11 (2017) No. 2 p. 221-228,
  13. Assia Konsoulova, Ivan Donev, Nikolay Conev, Sonya Draganova, Nadezhda Petrova, Eleonora Dimitrova, Hristo Popov, Kameliya Bratoeva, Petar Ghenev.First line 5-fu-based chemotherapy with/ without bevacizumab formetastatic colorectal cancer: tissue biomarker candidates.J of IMAB. 2016,22;(1):1038-1044. ISSN: 1312-773X
  14. M. Radanova, K. Bratoeva, N. Nazifova-Tasinova, M. Todorova, V. Vasilev, D. Ivanova "The GG rs292001 genotype prevails in seronegative for ANA and anti-dsDNA antibodies patients with lupus nephritis." Scripta Scientifica Medica, 48(3), 34-38, 2016.
  15. Mariya Kosturkova, Galya Mihaylova, Bogdan Rousev, Desislava Ivanova, Iliyan Kolev, Kameliya Bratoeva, Ivan Shterev, Мaria Radanova. Risk of development of solid tumors in patients with systemic lupus erythematosus. Варненски медицински форум; 2018; 7(2) 7-17. ISSN 2367-5519
  16. Bratoeva K, Dimitrova E, Conev N, Kashlov J, Panajotova E, Stoyanov G, Radanova M, Donev I. Expression of hepatic HMGB1 levels in fructose- induced fatty liver. Варненски медицински форум, 2018; 7(2): 151-157. ISSN 2367-5519
  17. M. Radanova, K. Bratoeva, V. Vasilev, B. Deliyska, V. Ikonomov, T. Argirova "Association between anti-C1q and anti-dsDNA antibodies in patients with Lupus nephritis" Science & Technologies, 10 (1), 55-60, 2015.




Член на

​Dr. Kameliya Bratoeva is a member of the European Federation of Physiological Sciences and the Bulgarian Physiological Society.